SLIT3 and colorectal carcinoma: These results suggest that an epigenetic inhibition of miR-218 by hypermethylation of the SLIT2 and SLIT3 promoter could be one of the reasons for MACC1 upregulation and its mediated poor survival of CRC patients and other cancer entities.